Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06396585
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-07
First Post:
2024-04-30
Brief Title:
The Efficacy and Safety of Tislelizumab Combined With Anlotinib and S1 Plus Oxaliplatin as Neoadjuvant Therapy for the Locally Advanced Adenocarcinoma of Esophagogastric Junction
Sponsor:
Fujian Cancer Hospital
Organization:
Fujian Cancer Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Immunotherapy Gastroesophageal Junction |
Keywords: